<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The administration of aprotinin has been associated with a reduction in cardiac surgery-related <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Intrinsic neuroprotective properties of this drug have not been evaluated in laboratory outcome models of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to determine whether aprotinin exhibits neuroprotective effects against either global or focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the rat </plain></SENT>
<SENT sid="3" pm="."><plain>Fasted rats were administered aprotinin (30,000 or 60,000 KIU/kg) or vehicle (0.9% <z:chebi fb="1" ids="26710">NaCl</z:chebi>) IV before global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (10 min bilateral carotid occlusion with mean arterial pressure 30 mm Hg) or focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (75 min of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> [MCAO]) </plain></SENT>
<SENT sid="4" pm="."><plain>Five days after global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the percentage of dead hippocampal CA1 neurons (mean +/- SD) was similar among the groups (small-dose aprotinin: 49+/-31, n = 15; large-dose aprotinin: 55+/-31, n = 13; vehicle: 47+/-31, n = 16; P = 0.74) </plain></SENT>
<SENT sid="5" pm="."><plain>After 7 days' recovery from MCAO, no difference among the groups was observed for either neurologic score (P = 0.99) or cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (small-dose aprotinin: 136+/-80 mm3, n = 23; large-dose aprotinin: 132+/-101 mm3, n = 11; vehicle: 121+/-81 mm3, n = 21; P = 0.87) </plain></SENT>
<SENT sid="6" pm="."><plain>IMPLICATIONS: Aprotinin offers no neuroprotection against either global or focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the rat when administered as a single preischemic bolus </plain></SENT>
</text></document>